Q4 2020
Released Feb 18, 2021, after the close
10-K filed Feb 19, 2021, 50 days after period end · 0001564590-21-006771
Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$2.99M-$2.99M derivedN/M vs Q4 2019N/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$3,013,442N/M
Operating Cash Flowderived-$1,949,085N/M
Free Cash Flowderived-$1,981,783N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Net Income | -$2.99M | -$1.98M | -$208.00K | -$1.60M |
| EPS Diluted | — | — | $0.00 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR